ANGPTL7: A Potential Drug Target and Biomarker for Angiopoietin-Inspired Therapies

Target Name: ANGPTL7

NCBI ID: G10218

ANGPTL7

ANGPTL7: A Potential Drug Target and Biomarker for Angiopoietin-Inspired Therapies

Angiopoietin-like 7 (ANGPTL7) is a protein that has been shown to promote blood vessel growth and repair, which can be a promising therapeutic approach for a variety of cardiovascular and other diseases. ANGPTL7 has also been shown to play a key role in the development and progression of various diseases, including cancer. As such, ANGPTL7 has potential as a drug target and biomarker for a variety of therapies.

Diseases and Therapies

One of the key applications of ANGPTL7 is its potential as a drug target. ANGPTL7 has been shown to promote the growth and development of blood vessels, which can be a useful target for therapies that are designed to improve blood flow and reduce the risk of cardiovascular disease. For example, ANGPTL7 has been shown to be involved in the development of atherosclerosis, a leading cause of heart disease, and has been shown to promote the formation of blood clots, which can also contribute to the development of cardiovascular disease.

angoPPTL7 has also been shown to be involved in the development of a variety of other diseases, including cancer. For example, ANGPTL7 has been shown to promote the growth and development of cancer cells, and has been shown to play a key role in the development of various types of cancer, including breast, ovarian, and prostate cancer. As such, ANGPTL7 has potential as a drug target for therapies that are designed to target cancer cells that have been shown to have ANGPTL7 activity.

Angiopoietin-Inspired Therapies

Another potential application of ANGPTL7 is its potential as a drug target or biomarker for therapies that are inspired by angiopoietin, a protein that has been shown to promote blood vessel growth and repair. Angiopoietin has been shown to be involved in a variety of physiological processes, including the regulation of blood pressure, blood flow, and inflammation. As such, ANGPTL7 has potential as a drug target or biomarker for therapies that are designed to mimic the effects of angiopoietin in order to improve blood flow and reduce the risk of cardiovascular and other diseases.

ANGPTL7 as a Biomarker

ANGPTL7 has also been shown to be a potential biomarker for a variety of cardiovascular and other diseases. For example, ANGPTL7 has been shown to be involved in the development and progression of atherosclerosis, a leading cause of heart disease, and has been shown to promote the formation of blood clots, which can contribute to the development of cardiovascular disease. As such, ANGPTL7 has potential as a biomarker for the development and progression of cardiovascular disease.

angoPPTL7 has also been shown to be involved in the development of a variety of other diseases, including cancer. For example, ANGPTL7 has been shown to promote the growth and development of cancer cells and has been shown to play a key role in the development of various types of cancer. As such, ANGPTL7 has potential as a biomarker for the development and progression of cancer.

Conclusion

In conclusion, ANGPTL7 has potential as a drug target and biomarker for a variety of cardiovascular and other diseases. ANGPTL7 has been shown to promote blood vessel growth and repair, and has been shown to play a key role in the development and progression of various diseases, including cancer. As such, ANGPTL7 has potential as a therapeutic approach for a variety of conditions, including cardiovascular disease and cancer. Further research is needed to fully understand the role of ANGPTL7

Protein Name: Angiopoietin Like 7

Functions: Has a role in the formation and organization of the extracellular matrix. In the eye, it functions as a mediator of dexamethasone-induced matrix deposition in the trabecular meshwork, the tissue responsible for the outflow of the ocular aqueous humor and for the maintenance of intraocular pressure (PubMed:21199193). Is a negative regulator of angiogenesis in the cornea, and plays a major role in maintaining corneal avascularity and transparency (PubMed:25622036)

The "ANGPTL7 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ANGPTL7 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets